Search Results
373 results
Your search is now limited to «AstraZeneca» expert search.
FierceMedicalDevices 01/17/2019 14:11
Berman has spent the past decade overseeing the rise of immuno-oncology drugs at AstraZeneca and Bristol-Myers Squibb, most recently as the head of AZ's franchise.
More from FierceMedicalDevices:
FierceBiotech 01/17/2019 09:38
Elsewhere, AstraZeneca lost another employee to Immunocore.
More from FierceBiotech:
PR Newswire 01/17/2019 05:00
AstraZeneca and Mspharma Jordan Are Topping the List of the Best Places to Work in Jordan for 2018.
More from PR Newswire:
Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China.
More from Pharmaceutical Business Review:
WN.com 01/16/2019 13:20
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field Luye ... ......
More from WN.com:
ENDPOINTS 01/16/2019 10:13
→ In what is being touted as the first time a multinational pharma company has secured a licence to sell a drug in China developed by a Chinese drugmaker, Luye Pharma on Wednesday said it had granted British drugmaker AstraZeneca $AZN the exclusive rights to promote its lipid-regulating Xuezhikang capsules, in mainland China.
More from ENDPOINTS:
pharmaphorum 01/16/2019 07:37
I re-entered industry in 2017 and the world has changed, with female representation at the highest levels in senior management here at AstraZeneca.
More from pharmaphorum:
BioPharma Dive 01/15/2019 08:40
Bohen, who became head of global medicines development for the drugmaker in 2015, will remain in place as CMO during the reorganization, a spokesperson for AstraZeneca confirmed to BioPharma Dive.
More from BioPharma Dive:
Becker's Hospital Review 01/14/2019 13:56
Leadership exodus continues at AstraZeneca, CMO to depart: 5 things to know.
More from Becker's Hospital Review:
Pharmafile 01/14/2019 09:59
AstraZeneca's chief medical officer announces resignation amid wave of departures.
More from Pharmafile:
PMLiVE 01/14/2019 06:48
Sean Bohen, chief medical officer, AZ Bohen joined AZ in 2015, coming from Roche’s Genentech unit where he was senior vice president of early development, and he is the fourth senior executive to depart in recent weeks.
More from PMLiVE:
News-Medical.net 01/10/2019 01:51
Jan 10 2019 Aptamer Group today announced it has signed an agreement with AstraZeneca to explore the potential of using aptamer technology to target the kidney.
More from News-Medical.net:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications